NASDAQ:MRNS
Marinus Pharmaceuticals, Inc.
- Stock
industry
Biotechnologyexchange
NASDAQ Global Marketwebsite
marinuspharma.comipo date
Jul 31, 2014full time employees
151currency
USD
Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of products for patients suffering from rare genetic epilepsies and other seizure disorders. It offers ZTALMY, an oral suspension for the treatment of seizures associated with cyclin-dependent kinas...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus